Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis.
暂无分享,去创建一个
W. Reddick | J. Langston | R. Ogg | P. Kingsley | J. S. Taylor | J. Jenkins | M. Pui | June S. Taylor | R. Sanford | J. Jenkins | R. Heideman | L. Kun | J. Ochs | G. Chen | Gang Chen | Larry E. Kun | J. Langston | L. Kun
[1] R. Zimmerman,et al. Proton MR spectroscopy of pediatric cerebellar tumors. , 1995, AJNR. American journal of neuroradiology.
[2] P. Wen,et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. , 1995, Neurosurgery.
[3] R. Zimmerman,et al. High-resolution 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro. , 1994, Journal of neurosurgery.
[4] P. Wen,et al. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas , 1994, Cancer.
[5] Ian C. P. Smith,et al. 1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.
[6] R. B. Kingsley,et al. WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. , 1994, Journal of magnetic resonance. Series B.
[7] P G Webb,et al. Automated single‐voxel proton MRS: Technical development and multisite verification , 1994, Magnetic resonance in medicine.
[8] B D Ross,et al. Absolute Quantitation of Water and Metabolites in the Human Brain. II. Metabolite Concentrations , 1993 .
[9] J H Duyn,et al. Multisection proton MR spectroscopic imaging of the brain. , 1993, Radiology.
[10] J. Frahm,et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. , 1993, Radiology.
[11] J Hennig,et al. Human brain tumors: assessment with in vivo proton MR spectroscopy. , 1993, Radiology.
[12] D J Vining,et al. Receiver operating characteristic curves: a basic understanding. , 1992, Radiographics : a review publication of the Radiological Society of North America, Inc.
[13] E. Alexander,et al. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. , 1992, Journal of neurosurgery.
[14] W. Negendank,et al. Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.
[15] J. Frahm,et al. On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro , 1992, NMR in biomedicine.
[16] D. Gusnard,et al. Proton magnetic resonance spectroscopy of pediatric brain tumors. , 1992, Neurosurgery.
[17] R. Lenkinski,et al. Proton MR Spectroscopy of Experimental Radiation‐Induced White Matter Injury , 1992, Journal of computer assisted tomography.
[18] D. Podoloff,et al. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. , 1992, Radiographics : a review publication of the Radiological Society of North America, Inc.
[19] Philip H. Gutin,et al. Radiation Injury to the Nervous System , 1991 .
[20] F. Shishido,et al. Clinical Value of Pet with 18F-Fluorodeoxyglucose and L-Methyl-11C-Methionine for Diagnosis of Recurrent Brain Tumor and Radiation Injury , 1991, Acta radiologica.
[21] W. Crist,et al. Common solid tumors of childhood. , 1991, The New England journal of medicine.
[22] J A Frank,et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. , 1990, Radiology.
[23] P R Luyten,et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. , 1990, Radiology.
[24] E. Shoubridge,et al. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.
[25] David G. Gadian,et al. Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.
[26] J C Mazziotta,et al. Thallium-201 SPECT imaging of brain tumors: methods and results. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] P. Gutin,et al. Stereotaxic irradiation of brain tumors , 1990, Cancer.
[28] C. Segebarth,et al. 1H image‐guided localized 31P MR spectroscopy of human brain: Quantitative analysis of 31P MR spectra measured on volunteers and on intracranial tumor patients , 1989, Magnetic resonance in medicine.
[29] J. Frahm,et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.
[30] C E Metz,et al. Some practical issues of experimental design and data analysis in radiological ROC studies. , 1989, Investigative radiology.
[31] Y. Olsson,et al. Positron Emission Tomography and Computed Tomography in Differential Diagnosis between Recurrent or Residual Glioma and Treatment-Induced Brain Lesions , 1989, Acta radiologica.
[32] J. Cohen,et al. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. , 1989, Cancer research.
[33] J. Cohen. Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance. , 1988, Mayo Clinic proceedings.
[34] P. Gutin,et al. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. , 1988, Journal of neurosurgery.
[35] J. S. Cohen,et al. 31P‐NMR spectroscopy of human cancer cells proliferating in a basement membrane gel , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] F. Shishido,et al. Delayed radiation necrosis of brain evaluated positron emission tomography. , 1988, The Tohoku journal of experimental medicine.
[37] P. Gutin,et al. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. , 1987, Journal of neurosurgery.
[38] C. Kufta,et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. , 1987, AJR. American journal of roentgenology.
[39] S. Green,et al. Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.
[40] H. Tewfik. Radiation Damage to the Nervous System , 1981 .
[41] O. G. Dodge,et al. Histological Typing of tumours of the Central Nervous System , 1981, British Journal of Cancer.
[42] J. Knake,et al. Failure of computerized tomography to differentiate between radiation necrosis and cerebral tumour. , 1978, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[43] O. H. Lowry,et al. DIVERSITY OF METABOLIC PATTERNS IN HUMAN BRAIN TUMORS—I. HIGH ENERGY PHOSPHATE COMPOUNDS AND BASIC COMPOSITION 1 , 1977, Journal of neurochemistry.
[44] M. Prados,et al. High activity iodine-125 interstitial implant for gliomas. , 1992, International journal of radiation oncology, biology, physics.
[45] C Van Ongeval,et al. Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. , 1991, Journal of computer assisted tomography.
[46] T. H. Newton,et al. Brain radiation lesions: MR imaging. , 1986, Radiology.